Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Multiple Sclerosis

Free Subscription 04.05.2026 1 Acta Neuropathol 1 AJNR Am J Neuroradiol 1 Arch Phys Med Rehabil 1 BMC Neurol 3 J Neurol 1 J Neurol Neurosurg Psychiatry 1 J Neurol Sci 6 Mult Scler 1 Neurologia (Engl Ed) 1 Rev Neurol 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. MISSAGLIA M, Filippi M, Esposito F, Giordano A, et al
   The hypoxia-inflammation cycle as a key mechanism of smoldering inflammation and progression in multiple sclerosis.
   Acta Neuropathol. 2026;151:49.
   PubMed         Abstract available
   
   

   
   AJNR Am J Neuroradiol

2. OKUDA DT, Stanley TA, McCreary MC, Burgess KW, et al
   Longitudinal Cortical Surface Signatures Distinguish Neuromyelitis Optica Spectrum Disorder from Multiple Sclerosis.
   AJNR Am J Neuroradiol. 2026 Apr 24:ajnr.A9371. doi: 10.3174/ajnr.A9371.
   PubMed         Abstract available
   
   

   
   Arch Phys Med Rehabil

3. VANNOSTRAND M, Ehde DM, Murphy SL, Alschuler KN, et al
   Examining the Impact of Perceived and Objective Cognitive Function on Social Participation in Individuals with Multiple Sclerosis.
   Arch Phys Med Rehabil. 2026 Apr 23:S0003-9993(26)00681.
   PubMed         Abstract available
   
   

   
   BMC Neurol

4. SAWAFTAH MA, AbuBaha M, AbuBaha B, Shoman M, et al
   Infliximab-associated multifocal central nervous system demyelination mimicking multiple sclerosis in a patient with Crohn's disease: a case report.
   BMC Neurol. 2026 Apr 30. doi: 10.1186/s12883-026-04932.
   PubMed         Abstract available
   
   

   
   J Neurol

5. IND G, Hashmi Z, Ahuja S, Fayad T, et al
   Demyelinating disorders in women: epidemiology, immunology, and clinical implications across MS, NMOSD, and MOGAD.
   J Neurol. 2026;273:290.
   PubMed         Abstract available
   
   
6. TUOMAALA J, Saraste M, Smith E, Kuusi M, et al
   Association between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study.
   J Neurol. 2026;273:298.
   PubMed         Abstract available
   
   
7. PENNER IK, Maier T, Wiemer T, Leemhuis J, et al
   Patient profiling in relapsing multiple sclerosis: insights from a real-world observational study into the unmet medical needs of patients on disease-modifying therapy.
   J Neurol. 2026;273:292.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

8. PORTACCIO E, Aprea MG, De Meo E, Betti M, et al
   Relapse-associated worsening in apolipoprotein E epsilon4 carriers with relapsing multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2026 Apr 30:jnnp-2025-338392.
   PubMed         Abstract available
   
   

   
   J Neurol Sci

9. ZHU Y, Zihan Ye
   Comment on "a proof-of-concept study on the relationship between lifetime estrogen exposure, menopausal transition, and neurodegeneration in women with multiple sclerosis".
   J Neurol Sci. 2026;486:125951.
   PubMed        
   
   

   
   Mult Scler

10. GUARNASCHELLI MF, Marrodan M, Sosa BE, Perez Arana CI, et al
    Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis.
    Mult Scler. 2026 Apr 29:13524585261442036. doi: 10.1177/13524585261442036.
    PubMed         Abstract available
    
    
11. SALTER A, Novak A, Lancia S, Cutter GR, et al
    Use of semaglutide and tirzepatide among people with multiple sclerosis.
    Mult Scler. 2026 Apr 29:13524585261442033. doi: 10.1177/13524585261442033.
    PubMed         Abstract available
    
    
12. GRECH L, Allan M, Skvarc D, Hamer R, et al
    Utility, validity, feasibility and acceptability of a clinician-administered depression, two-question screening tool for routine multiple sclerosis clinic administration.
    Mult Scler. 2026 Apr 26:13524585261435415. doi: 10.1177/13524585261435415.
    PubMed         Abstract available
    
    
13. LEMBO F, Fantozzi R, Collura A, Buttari F, et al
    Cladribine in multiple sclerosis with autoimmune comorbidities: Further clinical insights from patients with rheumatologic disease treated in combination with secukinumab.
    Mult Scler. 2026 Apr 26:13524585261441504. doi: 10.1177/13524585261441504.
    PubMed        
    
    
14. PENG X, Bjornevik K, Clish CB, Edan G, et al
    Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years.
    Mult Scler. 2026 Apr 26:13524585261435409. doi: 10.1177/13524585261435409.
    PubMed         Abstract available
    
    
15. HOLLEN C, Garcia C, Hemond CC, Spain RI, et al
    Filtered-phase imaging versus susceptibility-weighted imaging for paramagnetic rim lesion detection in multiple sclerosis: A head-to-head comparison.
    Mult Scler. 2026 Apr 26:13524585261439651. doi: 10.1177/13524585261439651.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

16. GARCIA DOMINGUEZ JM, Maria Villar L, Arrambide G, Blanco Y, et al
    Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases.
    Neurologia (Engl Ed). 2026;41:501928.
    PubMed         Abstract available
    
    

    
    Rev Neurol

17. INSENSER MB, Ruiz RL, Borges Guerra M, Dominguez EV, et al
    Implementation of a Program to Enhance Cognitive Reserve in Patients With Multiple Sclerosis (EM Reserva Program).
    Rev Neurol. 2026;81:48330.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

18. CALLOT V, Destruel A, Demortiere S, Testud B, et al
    7T magnetic resonance imaging of the human spinal cord in multiple sclerosis: Advances, insights and unmet needs.
    Rev Neurol (Paris). 2026 Apr 23:S0035-3787(26)00509.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum